Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Yi Guo, Ke Hu, Yuxuan Li, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Bidirectional causal associations between type 2 diabetes and COVID‐19
Hongbao Cao, Ancha Baranova, Xuejuan Wei, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 67
COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 326-326
Open Access | Times Cited: 46
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
Gerasimos Evangelatos, Giorgos Bamias, George D. Kitas, et al.
Rheumatology International (2022) Vol. 42, Iss. 9, pp. 1493-1511
Open Access | Times Cited: 61
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity
Kajal Gupta, Gaganpreet Kaur, Tejal Pathak, et al.
Gene (2022) Vol. 844, pp. 146790-146790
Open Access | Times Cited: 54
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review
Monika Gudowska-Sawczuk, Barbara Mroczko
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5283-5283
Open Access | Times Cited: 38
Immune responses in mildly versus critically ill COVID-19 patients
Hamid Nasrollahi, Atefe Ghamar Talepoor, Zahra Saleh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, et al.
Future Virology (2023) Vol. 18, Iss. 3, pp. 177-191
Open Access | Times Cited: 26
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
Joann Diray‐Arce, Slim Fourati, Naresh Doni Jayavelu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101079-101079
Open Access | Times Cited: 26
Galectin-3 as an important prognostic marker for COVID-19 severity
Nevena Gajović, Sofija Marković, Milena Jurišević, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Sea Cucumber and Blueberry Extracts Suppress Inflammation and Reduce Acute Lung Injury through the Regulation of NF-κB/MAPK/JNK Signaling Pathway in Lipopolysaccharide-Treated C57BL/6 Mice
Oladapo F. Fagbohun, Wasitha P. D. W. Thilakarathna, Juan Zhou, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1511-1511
Open Access | Times Cited: 5
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Aileen Faist, Josua Janowski, Sriram Kumar, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2198-2198
Open Access | Times Cited: 23
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, et al.
Molecular Immunology (2023) Vol. 156, pp. 111-126
Open Access | Times Cited: 13
Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Chaolin Huang, Xujuan Hu, Delong Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Endometriosis and COVID-19: A Systematic Review and Meta-Analysis
Ziyaana Kabani, Maria E. Ramos‐Niño, Prakash V. A. K. Ramdass
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12951-12951
Open Access | Times Cited: 18
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Sublingual Dissolving Microneedle (SLDMN)‐Based Vaccine for Inducing Mucosal Immunity against SARS‐CoV‐2
You-Seong Kim, In Ho Park, Jiwoo Shin, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Closed Access | Times Cited: 11
The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm—A Powerful Therapeutic Tool for COVID-19 Patients
Mária Csöbönyeiová, Veronika Smolinská, Stefan Harsanyi, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1736-1736
Open Access | Times Cited: 10
Identification of essential genes associated with SARS-CoV-2 infection as potential drug target candidates with machine learning algorithms
Golnaz Taheri, Mahnaz Habibi
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Nebulized Furosemide for Pulmonary Inflammation in Intubated Patients With COVID-19: A Phase 2 Randomized Controlled Double-Blind Study
John Muscedere, David M. Maslove, Christopher Barden, et al.
Critical Care Explorations (2024) Vol. 6, Iss. 2, pp. e1045-e1045
Open Access | Times Cited: 3
Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis
Laith Ashour
Tissue Barriers (2022) Vol. 11, Iss. 2
Open Access | Times Cited: 17
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators
Nusrath Yasmeen, Harikrishnan Selvaraj, Sudarshan Singh Lakhawat, et al.
Biochemical Pharmacology (2023) Vol. 209, pp. 115437-115437
Open Access | Times Cited: 9
Potential Utilization of Phenolic Acid Compounds as Anti-Inflammatory Agents through TNF-α Convertase Inhibition Mechanisms: A Network Pharmacology, Docking, and Molecular Dynamics Approach
Juni Ekowati, Bimo Ario Tejo, Saipul Maulana, et al.
ACS Omega (2023) Vol. 8, Iss. 49, pp. 46851-46868
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top